Patent: 7,744,886
✉ Email this page to a colleague
Summary for Patent: 7,744,886
Title: | Methods for interfering with rank signaling |
Abstract: | Disclosed herein are methods for interfering with RANK signaling by administering blocking antibodies that bind a RANKL polypeptide and inhibit the binding of the RANKL polypeptide to a RANK polypeptide. |
Inventor(s): | Anderson; Dirk M (Port Townsend, WA) |
Assignee: | Immunex Corporation (Thousand Oaks, CA) |
Application Number: | 12/214,914 |
Patent Claims: | see list of patent claims |
Details for Patent 7,744,886
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen, Inc. | PROLIA | denosumab | Injection | 125320 | 06/01/2010 | ⤷ Try a Trial | 2016-12-23 |
Amgen, Inc. | XGEVA | denosumab | Injection | 125320 | 11/18/2010 | ⤷ Try a Trial | 2016-12-23 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,744,886
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 9958674 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 9828426 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 9828424 | ⤷ Try a Trial |
United States of America | 8715683 | ⤷ Try a Trial |
United States of America | 8569456 | ⤷ Try a Trial |
United States of America | 8377690 | ⤷ Try a Trial |
United States of America | 8333963 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |